5 Einträge gefunden

1. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
2. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE
3. Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

   1. Tsourlakis, Maria Christina
   2. Schoop, Michael
   3. Plaß, Christoph
   4. Huland, Hartwig
   5. Graefen, Markus
   6. Steuber, Thomas
   7. Schlomm, Thorsten

   2013 - Forschungsinformationssystem des UKE
4. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
5. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

   1. Jacobsen, Frank
   2. Ashtiani, Sharad Nouraie
   3. Tennstedt, Pierre
   4. Heinzer, Hans
   5. Simon, Ronald
   6. Sauter, Guido
   7. Sirma, Hüseyin

   2013 - Forschungsinformationssystem des UKE